To eat or not to eat: dietary fat in uremia is the question.
暂无分享,去创建一个
[1] G. Kiziltan,et al. Nutrition-related cardiovascular risk factors in hemodialysis patients. , 2010, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[2] J. Carrero,et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] A. Tall,et al. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[4] B. Kestenbaum,et al. Obesity and change in estimated GFR among older adults. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[5] P. Schauer,et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[6] U. Risérus,et al. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. , 2009, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[7] M. Huang,et al. Measurement of vitamin D in foods and nutritional supplements by liquid chromatography/tandem mass spectrometry. , 2009, Journal of AOAC International.
[8] M. Laville,et al. Low protein diets for chronic kidney disease in non diabetic adults. , 2009, The Cochrane database of systematic reviews.
[9] T. Akizawa,et al. Vitamin D and vascular calcification in chronic kidney disease. , 2009, Bone.
[10] B. Rutkowski,et al. Temporal discrepancies in the association between the apoB/apoA‐I ratio and mortality in incident dialysis patients , 2009, Journal of internal medicine.
[11] W. Willett,et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. , 2009, The American journal of clinical nutrition.
[12] C. Zoccali,et al. Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. , 2009, Journal of the American College of Cardiology.
[13] Gert Mayer,et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.
[14] Keith C. Norris,et al. Reverse Cholesterol Transport Pathway in Experimental Chronic Renal Failure , 2009, American Journal of Nephrology.
[15] A. Hawasli,et al. Kidney transplant complications and obesity. , 2009, American journal of surgery.
[16] F. Dekker,et al. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. , 2009, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[17] T. Ikizler. Dietary protein restriction in CKD: the debate continues. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] Sun-Hee Park,et al. Definition of Metabolic Syndrome in Peritoneal Dialysis , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[19] J. Carrero,et al. Serum Retinol-Binding Protein Concentration and Its Association with Components of the Uremic Metabolic Syndrome in Nondiabetic Patients with Chronic Kidney Disease Stage 5 , 2008, American Journal of Nephrology.
[20] J. Axelsson. The emerging biology of adipose tissue in chronic kidney disease: from fat to facts. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] T. Ikizler. Resolved: being fat is good for dialysis patients: the Godzilla effect: pro. , 2008, Journal of the American Society of Nephrology : JASN.
[22] M. Czech,et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.
[23] F. Salvi,et al. Renin–angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans , 2008, Journal of hypertension.
[24] Peter Stenvinkel,et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[25] C. Wanner,et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. , 2008, Kidney international.
[26] M. Lazar,et al. Adipokines and the peripheral and neural control of energy balance. , 2008, Molecular endocrinology.
[27] B. C. Kwan,et al. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: A Story Half Untold: Adiposity, Adipokines and Outcomes in Dialysis Population , 2007, Seminars in dialysis.
[28] P. Stenvinkel,et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. , 2007, The American journal of clinical nutrition.
[29] G. Beck,et al. Body mass index and mortality in CKD. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] M. Murtaugh,et al. Associations of body size with metabolic syndrome and mortality in moderate chronic kidney disease. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[31] J. Griffith,et al. The Framingham predictive instrument in chronic kidney disease. , 2007, Journal of the American College of Cardiology.
[32] Renée de Mutsert,et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. , 2007, Journal of the American Society of Nephrology : JASN.
[33] J. Carrero,et al. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] K. Tucker,et al. alpha-Tocopherol intake and plasma concentration of Hispanic and non-Hispanic white elders is associated with dietary intake pattern. , 2006, The Journal of nutrition.
[35] F. Lönnqvist,et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. , 2006, Kidney international.
[36] P. Kimmel,et al. Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III). , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] W. März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.
[38] H. Gin,et al. Carbohydrate metabolism in uraemia , 2005, Current opinion in clinical nutrition and metabolic care.
[39] R. Cone,et al. Role of leptin and melanocortin signaling in uremia-associated cachexia. , 2005, The Journal of clinical investigation.
[40] L. Campbell,et al. Insulin resistance and postprandial triglyceride levels in primary renal disease. , 2005, Metabolism: clinical and experimental.
[41] P. Kent. Integrating clinical nutrition practice guidelines in chronic kidney disease. , 2005, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[42] K. Kalantar-Zadeh,et al. Survival advantages of obesity in dialysis patients. , 2005, The American journal of clinical nutrition.
[43] L. Niskanen,et al. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. , 2005, Archives of internal medicine.
[44] A. Bello,et al. Chronic kidney disease: the global challenge , 2005, The Lancet.
[45] S. Draibe,et al. Resting energy expenditure of chronic kidney disease patients: influence of renal function and subclinical inflammation. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[46] S. Draibe,et al. Decreased resting energy expenditure in non-dialysed chronic kidney disease patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[47] J. Woo,et al. Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients. , 2004, Journal of the American Society of Nephrology : JASN.
[48] P. Stenvinkel,et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. , 2004, The American journal of clinical nutrition.
[49] B. Egan,et al. Lipids enhance α1-adrenoceptor pressor sensitivity in patients with chronic kidney disease , 2004 .
[50] F. Lönnqvist,et al. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease. , 2004, Kidney international.
[51] S. Beddhu. Hypothesis: The Body Mass Index Paradox and an Obesity, Inflammation, and Atherosclerosis Syndrome in Chronic Kidney Disease , 2004, Seminars in dialysis.
[52] G. Bray,et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. , 2004, Circulation.
[53] M. Samore,et al. Effects of body size and body composition on survival in hemodialysis patients. , 2003, Journal of the American Society of Nephrology : JASN.
[54] T. Rabelink,et al. Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms. , 2003, Kidney international. Supplement.
[55] K. Kalantar-Zadeh,et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. , 2003, Kidney international.
[56] J. Ribaya-Mercado. Influence of dietary fat on beta-carotene absorption and bioconversion into vitamin A. , 2002, Nutrition reviews.
[57] C. Catena,et al. Abnormalities of glucose metabolism in patients with early renal failure. , 2002, Diabetes.
[58] N. Vaziri,et al. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure. , 2001, Kidney international.
[59] J W Erdman,et al. AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. , 2000, Circulation.
[60] G. Bray,et al. Dietary fat intake does affect obesity! , 1998, The American journal of clinical nutrition.
[61] F. Lönnqvist,et al. Low leptin gene expression and hyperleptinemia in chronic renal failure. , 1998, Kidney international.
[62] F. Lönnqvist,et al. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. , 1997, Journal of the American Society of Nephrology : JASN.
[63] P. Goldwasser,et al. Prealbumin and lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[64] G. Reaven,et al. Effect of chronic renal failure on high-density lipoprotein kinetics. , 1990, Kidney international.
[65] T. Steinman,et al. Nutritional status of patients with different levels of chronic renal insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. , 1989, Kidney international. Supplement.
[66] D. Levy,et al. Cholesterol and mortality. 30 years of follow-up from the Framingham study. , 1987, JAMA.
[67] J. Kopple,et al. Energy expenditure in patients with chronic renal failure. , 1986, Kidney international.
[68] I. Macdougall,et al. Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[69] G. Kaysen. Lipid and lipoprotein metabolism in chronic kidney disease. , 2009, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[70] A. Heng,et al. Assessment of body protein: energy status in chronic kidney disease. , 2009, Seminars in nephrology.
[71] K. Kalantar-Zadeh,et al. Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: effects of case mix and the malnutrition-inflammation-cachexia syndrome. , 2007, Journal of the American Society of Nephrology : JASN.
[72] P. Kris-Etherton,et al. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. , 2007, Journal of the American Dietetic Association.
[73] K. Kalantar-Zadeh,et al. Association between serum lipids and survival in hemodialysis patients and impact of race. , 2007, Journal of the American Society of Nephrology : JASN.
[74] S. Draibe,et al. Is energy intake underestimated in nondialyzed chronic kidney disease patients? , 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.
[75] O. Samuelsson,et al. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency. , 2002, Kidney international.
[76] E. Ritz,et al. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. The German Study Group Diabetes and Uremia. , 1993, Nephron.